Nutex Health Inc
NASDAQ:NUTX

Watchlist Manager
Nutex Health Inc Logo
Nutex Health Inc
NASDAQ:NUTX
Watchlist
Price: 175.78 USD -4.93% Market Closed
Market Cap: 1.2B USD

Intrinsic Value

The intrinsic value of one NUTX stock under the Base Case scenario is 394.64 USD. Compared to the current market price of 175.78 USD, Nutex Health Inc is Undervalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NUTX Intrinsic Value
394.64 USD
Undervaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Nutex Health Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about NUTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NUTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Nutex Health Inc.

Explain Valuation
Compare NUTX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NUTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nutex Health Inc

Current Assets 592.7m
Cash & Short-Term Investments 166m
Receivables 406.9m
Other Current Assets 19.7m
Non-Current Assets 371.9m
PP&E 335.9m
Intangibles 35.5m
Other Non-Current Assets 499k
Current Liabilities 185.5m
Accounts Payable 49.6m
Accrued Liabilities 105.5m
Short-Term Debt 5.3m
Other Current Liabilities 25.1m
Non-Current Liabilities 461.9m
Long-Term Debt 295.7m
Other Non-Current Liabilities 166.2m
Efficiency

Free Cash Flow Analysis
Nutex Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Nutex Health Inc

Revenue
981.2m USD
Cost of Revenue
-441.4m USD
Gross Profit
539.8m USD
Operating Expenses
-189.3m USD
Operating Income
350.5m USD
Other Expenses
-236.4m USD
Net Income
114.1m USD
Fundamental Scores

NUTX Profitability Score
Profitability Due Diligence

Nutex Health Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

61/100
Profitability
Score

Nutex Health Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

NUTX Solvency Score
Solvency Due Diligence

Nutex Health Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
69/100
Solvency
Score

Nutex Health Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NUTX Price Targets Summary
Nutex Health Inc

Wall Street analysts forecast NUTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NUTX is 255 USD with a low forecast of 222.2 USD and a high forecast of 315 USD.

Lowest
Price Target
222.2 USD
26% Upside
Average
Price Target
255 USD
45% Upside
Highest
Price Target
315 USD
79% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Nutex Health Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NUTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

NUTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one NUTX stock?

The intrinsic value of one NUTX stock under the Base Case scenario is 394.64 USD.

Is NUTX stock undervalued or overvalued?

Compared to the current market price of 175.78 USD, Nutex Health Inc is Undervalued by 55%.

Back to Top